Cargando…
Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
Selective blockers of the Kv1.5 channel have been developed for the treatment of atrial fibrillation (AF), but little is known how these atrial-selective drugs affect human action potentials (APs). Therefore we have investigated the Kv1.5 blocker MK-0448 (N-{6-[(1S)-1-(4-fluorophenyl)-2,2-di(pyridin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940943/ https://www.ncbi.nlm.nih.gov/pubmed/24624083 http://dx.doi.org/10.3389/fphar.2014.00026 |
_version_ | 1782305840921837568 |
---|---|
author | Loose, Simone Mueller, Judith Wettwer, Erich Knaut, Michael Ford, John Milnes, James Ravens, Ursula |
author_facet | Loose, Simone Mueller, Judith Wettwer, Erich Knaut, Michael Ford, John Milnes, James Ravens, Ursula |
author_sort | Loose, Simone |
collection | PubMed |
description | Selective blockers of the Kv1.5 channel have been developed for the treatment of atrial fibrillation (AF), but little is known how these atrial-selective drugs affect human action potentials (APs). Therefore we have investigated the Kv1.5 blocker MK-0448 (N-{6-[(1S)-1-(4-fluorophenyl)-2,2-di(pyridin-3-yl)ethyl]pyridin-2-yl}methanesulfon- amide) in right atrial trabeculae from patients in sinus rhythm (SR), permanent AF (>6 months), and intermittent AF. MK-0448 blocked Kv1.5 current in an expression system and concentration-dependently elevated the plateau phase of atrial APs. In SR preparations stimulated at 1 Hz, MK-0448 (3 μM) shortened action potential duration at 90% of repolarization (APD(90)) and effective refractory period (ERP), but in permanent AF preparations, MK-0448 prolonged APD(90) and ERP. The effects of MK-0448 in intermittent AF resembled those in SR preparations. Block of I(Ks) is probably more prominent in AF because of reduced repolarization reserve due to AF-induced remodeling. |
format | Online Article Text |
id | pubmed-3940943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39409432014-03-12 Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation Loose, Simone Mueller, Judith Wettwer, Erich Knaut, Michael Ford, John Milnes, James Ravens, Ursula Front Pharmacol Pharmacology Selective blockers of the Kv1.5 channel have been developed for the treatment of atrial fibrillation (AF), but little is known how these atrial-selective drugs affect human action potentials (APs). Therefore we have investigated the Kv1.5 blocker MK-0448 (N-{6-[(1S)-1-(4-fluorophenyl)-2,2-di(pyridin-3-yl)ethyl]pyridin-2-yl}methanesulfon- amide) in right atrial trabeculae from patients in sinus rhythm (SR), permanent AF (>6 months), and intermittent AF. MK-0448 blocked Kv1.5 current in an expression system and concentration-dependently elevated the plateau phase of atrial APs. In SR preparations stimulated at 1 Hz, MK-0448 (3 μM) shortened action potential duration at 90% of repolarization (APD(90)) and effective refractory period (ERP), but in permanent AF preparations, MK-0448 prolonged APD(90) and ERP. The effects of MK-0448 in intermittent AF resembled those in SR preparations. Block of I(Ks) is probably more prominent in AF because of reduced repolarization reserve due to AF-induced remodeling. Frontiers Media S.A. 2014-03-04 /pmc/articles/PMC3940943/ /pubmed/24624083 http://dx.doi.org/10.3389/fphar.2014.00026 Text en Copyright © 2014 Loose, Mueller, Wettwer, Knaut, Ford, Milnes and Ravens. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Loose, Simone Mueller, Judith Wettwer, Erich Knaut, Michael Ford, John Milnes, James Ravens, Ursula Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
title | Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
title_full | Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
title_fullStr | Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
title_full_unstemmed | Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
title_short | Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
title_sort | effects of i(kur) blocker mk-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940943/ https://www.ncbi.nlm.nih.gov/pubmed/24624083 http://dx.doi.org/10.3389/fphar.2014.00026 |
work_keys_str_mv | AT loosesimone effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation AT muellerjudith effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation AT wettwererich effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation AT knautmichael effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation AT fordjohn effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation AT milnesjames effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation AT ravensursula effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation |